Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001209191-23-042658

Chief Business Officer acquired 35,156 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hull Hans Chief Business Officer 2023-07-14 Grant or award +35,156 237,120 D
Loading xslF345X05/doc4.xml…